3/2
09:27 am
gmab
Genmab A/S (GMAB) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $40.00 price target on the stock.
Low
Report
Genmab A/S (GMAB) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $40.00 price target on the stock.
3/2
09:14 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
3/2
09:14 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
3/2
06:01 am
gmab
Genmab initiated with an Overweight at Wells Fargo
Low
Report
Genmab initiated with an Overweight at Wells Fargo
3/2
06:01 am
gmab
Genmab initiated with an Overweight at Wells Fargo
Low
Report
Genmab initiated with an Overweight at Wells Fargo
2/23
11:58 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
2/23
11:58 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
2/17
09:48 am
gmab
Rating for GMAB
Medium
Report
Rating for GMAB
2/17
09:48 am
gmab
Rating for GMAB
Medium
Report
Rating for GMAB
2/16
08:05 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
2/16
08:05 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
2/16
07:27 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
2/16
07:27 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
1/28
08:46 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $39.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $39.00 price target on the stock.